SAN DIEGO, CALIF. – (July 31, 2017) – Beckman Coulter Life Sciences has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest clinical flow cytometry product, the ...
Beckman Coulter Life Sciences continues to expand its portfolio of clinical flow cytometry solutions with its latest innovations ranging from portfolio extensions to its range of single-color ...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the ...
Miami, USA (July 13, 2017) - Beckman Coulter Life Sciences welcomes the announcement from the Food and Drug Administration (FDA) that it had received regulatory clearance (via the De Novo Process) to ...
Beckman Coulter Life Sciences acquired the flow cytometry business of India’s ReaMetrix, in a deal that broadens the buyer’s tool and technology offerings to include reagents designed to simplify ...
DUBLIN, June 1, 2021 /PRNewswire/ -- The "Flow Cytometry Market Based on Technology, Product and Service, Application, End-User, and Geography - Global Forecast up to 2026" report has been added to ...
Join us every Thursday, 2-3 p.m., in Beckman B181. Office hours are open to all researchers; no registration required. Just drop by! The Fluorescence Activated Cell Sorting (FACS) Facility is hosting ...
Transaction allows Beckman to offer a more comprehensive range of research solutions to customers. Beckman Coulter will acquire Dako Denmark’s research flow cytometry instrumentation business. “We are ...
DUBLIN, Feb. 26, 2020 /PRNewswire/ -- The "Flow Cytometry Market by Product and Solution (Consumables, Instrument, Software, Service), Technology (Cell-based, Bead ...
Beckman Coulter Life Sciences, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research. Under ...
Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results